PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies.
about
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target.
P2860
PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
PRIMA-1 and PRIMA-1Met (APR-24 ...... ct in Combinatorial Therapies.
@en
PRIMA-1 and PRIMA-1Met
@nl
type
label
PRIMA-1 and PRIMA-1Met (APR-24 ...... ct in Combinatorial Therapies.
@en
PRIMA-1 and PRIMA-1Met
@nl
prefLabel
PRIMA-1 and PRIMA-1Met (APR-24 ...... ct in Combinatorial Therapies.
@en
PRIMA-1 and PRIMA-1Met
@nl
P2093
P2860
P356
P1433
P1476
PRIMA-1 and PRIMA-1Met (APR-24 ...... ct in Combinatorial Therapies.
@en
P2093
Ahmad Awada
Anne Perdrix
Fabrice Journe
Ghanem Ghanem
Mohammad Krayem
Sven Saussez
P2860
P356
10.3390/CANCERS9120172
P50
P577
2017-12-16T00:00:00Z